AIDS

1. TAO K, Tzou PL, Sahoo MK, Hare CB, et al
   HIV-1 subtype diversity trends in a Northern California cohort.
   AIDS. 2026;40:530-532.
   

   >> Share

   
   

   
   Am J Trop Med Hyg

2. MUNYEMANA JB, Uwizeyimana G, Ndayisaba MC, Dusabe A, et al
   Antimicrobial Resistance in Uropathogens at the University Teaching Hospital of Kigali, Rwanda: A 5-Year Surveillance Study.
   Am J Trop Med Hyg. 2026 Feb 24:tpmd250558. doi: 10.4269/ajtmh.25-0558.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

3. CHEN J, Sun Z, Su J, Li P, et al
   Functional characterization of a novel class A carbapenemase CAE-1 in carbapenem-resistant Pseudomonas aeruginosa clinical isolates.
   Antimicrob Agents Chemother. 2026 Feb 23:e0136225. doi: 10.1128/aac.01362.
   

   >> Share

   
   
4. ZHANG R, Zhang C, Liu J, Kong X, et al
   Therapeutic effect of eravacycline against carbapenem-resistant hypervirulent Klebsiella pneumoniae in mouse models.
   Antimicrob Agents Chemother. 2026 Feb 23:e0123725. doi: 10.1128/aac.01237.
   

   >> Share

   
   

   
   Clin Infect Dis

5. MITCHELL KK, Smith AC, Ayala JC, Schmerer MW, et al
   Review of Methods for Detecting Antimicrobial Resistance of Neisseria gonorrhoeae.
   Clin Infect Dis. 2026;82.
   

   >> Share

   
   
6. STERKEL AK, Loya TJ, Smith AC, Southern T, et al
   Narrative Review of Chlamydia trachomatis Culture, Viability Testing, and Sequencing Methods.
   Clin Infect Dis. 2026;82.
   

   >> Share

   
   

   
   Int J Antimicrob Agents

7. YUAN Q, Liu SL, Luan L, Jiang YT, et al
   Development and validation of a predictive model for profiling antibiotic resistance phenotypes of Acinetobacter baumannii strains via clinical MALDI-TOF mass spectra: a multicenter study.
   Int J Antimicrob Agents. 2026 Feb 25:107760.
   

   >> Share

   
   
8. SHEN F, Liu X, Lei T, Quan J, et al
   cirA Promoter Disruption and SHV-12 Production Contribute to Cefiderocol Resistance in Carbapenem-Resistant Klebsiella pneumoniae.
   Int J Antimicrob Agents. 2026 Feb 24:107756.
   

   >> Share

   
   

   
   J Antimicrob Chemother

9. FAN Y, Liang X, Ren Y, Nie S, et al
   A two-stage diagnostic model for discriminating and assessing risk of meropenem heteroresistance in Pseudomonas aeruginosa.
   J Antimicrob Chemother. 2026;81:dkag061.
   

   >> Share

   
   
10. PEZZATI L, Conti F, Gennari W, Mussini C, et al
    Switching to bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and prior resistance mutations. Data from the Italian ARCA cohort: the BIC-BARRIER study. B/F/TAF switch: mutations and outcomes.
    J Antimicrob Chemother. 2026;81:dkag035.
    

    >> Share

    
    
11. ISLAM R, Das SC, Pletzer D
    Combating multidrug-resistant Klebsiella pneumoniae: current therapeutic regimens and future directions.
    J Antimicrob Chemother. 2026;81:dkag064.
    

    >> Share

    
    

    
    J Infect Dis

12. AZNAR FERNANDEZ M, Rodriguez-Villodres A, Gomez-Gomez MJ, Cisneros JM, et al
    Novel KPC-2 Plasmid in a Clinical Salmonella Rissen Selected by Antibiotic Pressure.
    J Infect Dis. 2026;233:328-333.
    

    >> Share

    
    
13. MARIN JEO, Boza MJL, Camargo CH, Campos KR, et al
    Stepwise Evolution of Triple Antimicrobial Resistance in Neisseria meningitidis.
    J Infect Dis. 2026 Feb 23:jiag113. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Microbiol

14. KINGDON ADH, Jordana-Lluch E, Hardie KR
    Can commensals alter pathogen's antibiotic resistance during co-culture?
    J Med Microbiol. 2026;75:002126.
    

    >> Share

    
    

    
    PLoS One

15. ZHANG H, Wu P, Ye W
    HIV-1 drug resistance and associated risk factors in patients with antiretroviral therapy failure in Chongqing, China, 2019-2023.
    PLoS One. 2026;21:e0342301.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share